Vertex Pharmaceuticals (VRTX +6.1%) lands FDA approval for its cystic fibrosis drug Kalydeco for...

|About: Vertex Pharmaceuticals In... (VRTX)|By:, SA News Editor

Vertex Pharmaceuticals (VRTX +6.1%) lands FDA approval for its cystic fibrosis drug Kalydeco for patients over 6 years of age. Shares immediately spiked higher on the news - taking back ground lost yesterday after the firm's 2012 sales estimates for Incivek came in light.